nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—Estropipate—SLC22A1—hematologic cancer	0.00796	0.105	CrCbGaD
Equilin—Conjugated Estrogens—ABCC3—hematologic cancer	0.00715	0.094	CrCbGaD
Equilin—Estriol—ESR1—hematologic cancer	0.00713	0.0938	CrCbGaD
Equilin—Estropipate—ESR1—hematologic cancer	0.00545	0.0717	CrCbGaD
Equilin—Estradiol—UGT1A1—hematologic cancer	0.00467	0.0614	CrCbGaD
Equilin—Ethinyl Estradiol—ESR1—hematologic cancer	0.00389	0.0512	CrCbGaD
Equilin—Estradiol—SLC22A1—hematologic cancer	0.00376	0.0494	CrCbGaD
Equilin—Conjugated Estrogens—ABCG2—hematologic cancer	0.00347	0.0457	CrCbGaD
Equilin—Estrone—ABCG2—hematologic cancer	0.00346	0.0456	CrCbGaD
Equilin—Conjugated Estrogens—ESR1—hematologic cancer	0.0034	0.0448	CrCbGaD
Equilin—Estrone—ESR1—hematologic cancer	0.00339	0.0446	CrCbGaD
Equilin—Estradiol—AR—hematologic cancer	0.00334	0.0439	CrCbGaD
Equilin—HSD17B1—Disease—HDAC9—hematologic cancer	0.00311	0.00337	CbGpPWpGaD
Equilin—HSD17B1—Disease—H3F3B—hematologic cancer	0.00308	0.00333	CbGpPWpGaD
Equilin—Estriol—ABCB1—hematologic cancer	0.00303	0.0398	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	0.00298	0.00323	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ARNTL—hematologic cancer	0.00298	0.00322	CbGpPWpGaD
Equilin—HSD17B1—Disease—NPM1—hematologic cancer	0.00297	0.00321	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CA9—hematologic cancer	0.00289	0.00313	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ACP5—hematologic cancer	0.00289	0.00313	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOR2—hematologic cancer	0.00286	0.00309	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF19—hematologic cancer	0.00284	0.00307	CbGpPWpGaD
Equilin—HSD17B1—Disease—RPS14—hematologic cancer	0.00282	0.00305	CbGpPWpGaD
Equilin—HSD17B1—Disease—DKK1—hematologic cancer	0.0028	0.00303	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL17—hematologic cancer	0.00279	0.00302	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AGRN—hematologic cancer	0.00279	0.00302	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT5B—hematologic cancer	0.00277	0.003	CbGpPWpGaD
Equilin—HSD17B1—Disease—NUP98—hematologic cancer	0.00277	0.003	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCR5—hematologic cancer	0.00274	0.00297	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—IDH1—hematologic cancer	0.00272	0.00295	CbGpPWpGaD
Equilin—HSD17B1—Disease—CST3—hematologic cancer	0.00271	0.00294	CbGpPWpGaD
Equilin—HSD17B1—Disease—ADCY7—hematologic cancer	0.00269	0.00291	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LEF1—hematologic cancer	0.00269	0.00291	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCC3—hematologic cancer	0.00269	0.00291	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TXN—hematologic cancer	0.00269	0.00291	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTO1—hematologic cancer	0.00269	0.00291	CbGpPWpGaD
Equilin—HSD17B1—Disease—NUP214—hematologic cancer	0.00267	0.00289	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNA13—hematologic cancer	0.00265	0.00286	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SPHK1—hematologic cancer	0.00263	0.00285	CbGpPWpGaD
Equilin—Estradiol—ABCG2—hematologic cancer	0.00262	0.0345	CrCbGaD
Equilin—HSD17B1—Disease—XIAP—hematologic cancer	0.00262	0.00283	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTR—hematologic cancer	0.00262	0.00283	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TIAM1—hematologic cancer	0.0026	0.00282	CbGpPWpGaD
Equilin—Estradiol—ESR1—hematologic cancer	0.00257	0.0338	CrCbGaD
Equilin—HSD17B1—Disease—ENO2—hematologic cancer	0.00257	0.00278	CbGpPWpGaD
Equilin—HSD17B1—Disease—SMARCA4—hematologic cancer	0.00255	0.00276	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—UGT1A1—hematologic cancer	0.00253	0.00274	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JAK3—hematologic cancer	0.00252	0.00273	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC22A1—hematologic cancer	0.00246	0.00266	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CRABP1—hematologic cancer	0.00246	0.00266	CbGpPWpGaD
Equilin—HSD17B1—Disease—SDC1—hematologic cancer	0.00244	0.00264	CbGpPWpGaD
Equilin—Estropipate—ALB—hematologic cancer	0.00243	0.0319	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—CCR7—hematologic cancer	0.00242	0.00262	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL13—hematologic cancer	0.00242	0.00262	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALOX5—hematologic cancer	0.0024	0.0026	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NCOR2—hematologic cancer	0.00239	0.00259	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CRKL—hematologic cancer	0.00236	0.00255	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL3RA—hematologic cancer	0.00236	0.00255	CbGpPWpGaD
Equilin—HSD17B1—Disease—LCK—hematologic cancer	0.00236	0.00255	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NUP98—hematologic cancer	0.00232	0.00251	CbGpPWpGaD
Equilin—HSD17B1—Disease—H3F3A—hematologic cancer	0.00231	0.0025	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RGS2—hematologic cancer	0.00228	0.00246	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOA3—hematologic cancer	0.00226	0.00244	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ADCY7—hematologic cancer	0.00226	0.00244	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TRH—hematologic cancer	0.00225	0.00244	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CMA1—hematologic cancer	0.00225	0.00244	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TRIO—hematologic cancer	0.00225	0.00244	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRKCZ—hematologic cancer	0.00225	0.00243	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NUP214—hematologic cancer	0.00224	0.00242	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	0.00222	0.0024	CbGpPWpGaD
Equilin—HSD17B1—Disease—CALR—hematologic cancer	0.00221	0.00239	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SPHK1—hematologic cancer	0.0022	0.00238	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AGO2—hematologic cancer	0.0022	0.00238	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCG2—hematologic cancer	0.00219	0.00237	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTR—hematologic cancer	0.00219	0.00237	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HDAC9—hematologic cancer	0.00218	0.00236	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LPAR1—hematologic cancer	0.00218	0.00236	CbGpPWpGaD
Equilin—HSD17B1—Disease—PARP1—hematologic cancer	0.00217	0.00235	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—H3F3B—hematologic cancer	0.00216	0.00233	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ENO2—hematologic cancer	0.00215	0.00233	CbGpPWpGaD
Equilin—HSD17B1—Disease—FBXW7—hematologic cancer	0.00214	0.00231	CbGpPWpGaD
Equilin—HSD17B1—Disease—CXCR4—hematologic cancer	0.00209	0.00227	CbGpPWpGaD
Equilin—HSD17B1—Disease—HDAC2—hematologic cancer	0.00209	0.00227	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTT1—hematologic cancer	0.00209	0.00226	CbGpPWpGaD
Equilin—HSD17B1—Disease—CD44—hematologic cancer	0.00207	0.00224	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	0.00205	0.00222	CbGpPWpGaD
Equilin—HSD17B1—Disease—CBL—hematologic cancer	0.00204	0.00221	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SDC1—hematologic cancer	0.00204	0.00221	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDE4B—hematologic cancer	0.00201	0.00217	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CNR2—hematologic cancer	0.00201	0.00217	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF19—hematologic cancer	0.00199	0.00215	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RAC2—hematologic cancer	0.00197	0.00214	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DKK1—hematologic cancer	0.00196	0.00212	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	0.00195	0.00211	CbGpPWpGaD
Equilin—HSD17B1—Disease—HSP90AA1—hematologic cancer	0.00195	0.00211	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT5B—hematologic cancer	0.00194	0.0021	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	0.00192	0.00208	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADCY7—hematologic cancer	0.00189	0.00204	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT1—hematologic cancer	0.00188	0.00203	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	0.00184	0.00199	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—XIAP—hematologic cancer	0.00183	0.00199	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SH2B3—hematologic cancer	0.00179	0.00193	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SMARCA4—hematologic cancer	0.00179	0.00193	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GZMB—hematologic cancer	0.00178	0.00192	CbGpPWpGaD
Equilin—HSD17B1—Disease—GRB2—hematologic cancer	0.00176	0.0019	CbGpPWpGaD
Equilin—HSD17B1—Disease—PDGFA—hematologic cancer	0.00175	0.0019	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CTNNA1—hematologic cancer	0.00173	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CD44—hematologic cancer	0.00173	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NQO1—hematologic cancer	0.00173	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Disease—KITLG—hematologic cancer	0.00173	0.00187	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EIF4EBP1—hematologic cancer	0.00172	0.00187	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HSPB1—hematologic cancer	0.00172	0.00187	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL3—hematologic cancer	0.00172	0.00187	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SDC1—hematologic cancer	0.00171	0.00185	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTHLH—hematologic cancer	0.00171	0.00185	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	0.0017	0.00184	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT5A—hematologic cancer	0.00169	0.00183	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN2B—hematologic cancer	0.00167	0.00181	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTGER4—hematologic cancer	0.00166	0.0018	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ABCB1—hematologic cancer	0.00165	0.0218	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—LCK—hematologic cancer	0.00165	0.00179	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYCS—hematologic cancer	0.00164	0.00178	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSP90AA1—hematologic cancer	0.00163	0.00176	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—H3F3A—hematologic cancer	0.00162	0.00175	CbGpPWpGaD
Equilin—HSD17B1—Disease—CD86—hematologic cancer	0.00162	0.00175	CbGpPWpGaD
Equilin—HSD17B1—Disease—HES1—hematologic cancer	0.0016	0.00173	CbGpPWpGaD
Equilin—HSD17B1—Disease—NCOR1—hematologic cancer	0.00159	0.00172	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCZ—hematologic cancer	0.00157	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF1—hematologic cancer	0.00157	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Disease—FOXO1—hematologic cancer	0.00155	0.00167	CbGpPWpGaD
Equilin—HSD17B1—Disease—PDGFRB—hematologic cancer	0.00154	0.00167	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PARP1—hematologic cancer	0.00152	0.00164	CbGpPWpGaD
Equilin—HSD17B1—Disease—PDGFRA—hematologic cancer	0.00152	0.00164	CbGpPWpGaD
Equilin—HSD17B1—Disease—JAK1—hematologic cancer	0.00151	0.00164	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRKCG—hematologic cancer	0.00151	0.00164	CbGpPWpGaD
Equilin—Estrone—ALB—hematologic cancer	0.00151	0.0199	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—FBXW7—hematologic cancer	0.0015	0.00162	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	0.00147	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCR4—hematologic cancer	0.00147	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HDAC2—hematologic cancer	0.00147	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTP1—hematologic cancer	0.00145	0.00157	CbGpPWpGaD
Equilin—Conjugated Estrogens—ABCB1—hematologic cancer	0.00145	0.019	CrCbGaD
Equilin—Estrone—ABCB1—hematologic cancer	0.00144	0.019	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—CBL—hematologic cancer	0.00143	0.00155	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL3—hematologic cancer	0.00141	0.00153	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTHFR—hematologic cancer	0.0014	0.00152	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	0.0014	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Disease—TERT—hematologic cancer	0.0014	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Disease—HLA-A—hematologic cancer	0.0014	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTPN1—hematologic cancer	0.00139	0.0015	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCB1—hematologic cancer	0.00137	0.00148	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RASGRP1—hematologic cancer	0.00137	0.00148	CbGpPWpGaD
Equilin—HSD17B1—Disease—PDGFB—hematologic cancer	0.00137	0.00148	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SYK—hematologic cancer	0.00136	0.00148	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HSP90AA1—hematologic cancer	0.00136	0.00148	CbGpPWpGaD
Equilin—HSD17B1—Disease—TSC2—hematologic cancer	0.00133	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOR1—hematologic cancer	0.00133	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTM1—hematologic cancer	0.00133	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT1—hematologic cancer	0.00131	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGFR3—hematologic cancer	0.00128	0.00139	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GRB2—hematologic cancer	0.00123	0.00133	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDGFA—hematologic cancer	0.00123	0.00133	CbGpPWpGaD
Equilin—HSD17B1—Disease—BAD—hematologic cancer	0.00122	0.00132	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KITLG—hematologic cancer	0.00121	0.00131	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOTCH1—hematologic cancer	0.00121	0.0013	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT5A—hematologic cancer	0.00118	0.00128	CbGpPWpGaD
Equilin—HSD17B1—Disease—CD80—hematologic cancer	0.00118	0.00128	CbGpPWpGaD
Equilin—HSD17B1—Disease—KIT—hematologic cancer	0.00118	0.00128	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTHFR—hematologic cancer	0.00117	0.00127	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN2B—hematologic cancer	0.00117	0.00127	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTPN11—hematologic cancer	0.00116	0.00125	CbGpPWpGaD
Equilin—Estradiol—ALB—hematologic cancer	0.00114	0.0151	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—CD86—hematologic cancer	0.00113	0.00123	CbGpPWpGaD
Equilin—HSD17B1—Disease—CREB1—hematologic cancer	0.00112	0.00121	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HES1—hematologic cancer	0.00112	0.00121	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NCOR1—hematologic cancer	0.00111	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Disease—BRAF—hematologic cancer	0.00111	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CSF2—hematologic cancer	0.0011	0.00119	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF1—hematologic cancer	0.0011	0.00119	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6R—hematologic cancer	0.00109	0.00118	CbGpPWpGaD
Equilin—HSD17B1—Disease—CREBBP—hematologic cancer	0.00109	0.00118	CbGpPWpGaD
Equilin—Estradiol—ABCB1—hematologic cancer	0.00109	0.0144	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—FOXO1—hematologic cancer	0.00108	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDGFRB—hematologic cancer	0.00108	0.00117	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDGFRA—hematologic cancer	0.00106	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JAK1—hematologic cancer	0.00106	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCG—hematologic cancer	0.00106	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAP2K1—hematologic cancer	0.00104	0.00113	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CD—hematologic cancer	0.00104	0.00112	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	0.00104	0.00112	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF2—hematologic cancer	0.000992	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL2RA—hematologic cancer	0.000991	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CG—hematologic cancer	0.000987	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TERT—hematologic cancer	0.000979	0.00106	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3R1—hematologic cancer	0.000978	0.00106	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDGFB—hematologic cancer	0.000956	0.00103	CbGpPWpGaD
Equilin—HSD17B1—Disease—JAK2—hematologic cancer	0.000951	0.00103	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TSC2—hematologic cancer	0.000934	0.00101	CbGpPWpGaD
Equilin—HSD17B1—Disease—MDM2—hematologic cancer	0.000928	0.001	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CREBBP—hematologic cancer	0.000915	0.00099	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CB—hematologic cancer	0.000903	0.000977	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTOR—hematologic cancer	0.000903	0.000977	CbGpPWpGaD
Equilin—HSD17B1—Disease—CD4—hematologic cancer	0.000901	0.000975	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGFR3—hematologic cancer	0.000899	0.000973	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK14—hematologic cancer	0.00089	0.000963	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ESR1—hematologic cancer	0.000873	0.000945	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CD—hematologic cancer	0.000868	0.000939	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FN1—hematologic cancer	0.000862	0.000933	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALB—hematologic cancer	0.000856	0.000927	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BAD—hematologic cancer	0.000852	0.000922	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NFKBIA—hematologic cancer	0.000852	0.000922	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN1B—hematologic cancer	0.000847	0.000917	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOTCH1—hematologic cancer	0.000844	0.000913	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CD80—hematologic cancer	0.000827	0.000895	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KIT—hematologic cancer	0.000825	0.000893	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CG—hematologic cancer	0.000825	0.000893	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3R1—hematologic cancer	0.000819	0.000887	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTPN11—hematologic cancer	0.000811	0.000877	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CREB1—hematologic cancer	0.000785	0.00085	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN1A—hematologic cancer	0.000782	0.000846	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTEN—hematologic cancer	0.00078	0.000844	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BRAF—hematologic cancer	0.000776	0.000839	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL2—hematologic cancer	0.000769	0.000832	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6R—hematologic cancer	0.000766	0.000829	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CREBBP—hematologic cancer	0.000765	0.000828	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CB—hematologic cancer	0.000756	0.000818	CbGpPWpGaD
Equilin—HSD17B1—Disease—EP300—hematologic cancer	0.000744	0.000805	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAP2K1—hematologic cancer	0.00073	0.00079	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CD—hematologic cancer	0.000725	0.000785	CbGpPWpGaD
Equilin—HSD17B1—Disease—SRC—hematologic cancer	0.000724	0.000783	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT3—hematologic cancer	0.000698	0.000755	CbGpPWpGaD
Equilin—HSD17B1—Disease—NRAS—hematologic cancer	0.000696	0.000753	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF2—hematologic cancer	0.000695	0.000752	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3R1—hematologic cancer	0.000685	0.000741	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAPK3—hematologic cancer	0.000667	0.000722	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JAK2—hematologic cancer	0.000666	0.000721	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTEN—hematologic cancer	0.000653	0.000707	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MDM2—hematologic cancer	0.00065	0.000703	CbGpPWpGaD
Equilin—HSD17B1—Disease—MYC—hematologic cancer	0.000648	0.000702	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFB1—hematologic cancer	0.000647	0.0007	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CB—hematologic cancer	0.000632	0.000684	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MTOR—hematologic cancer	0.000632	0.000684	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—EP300—hematologic cancer	0.000623	0.000674	CbGpPWpGaD
Equilin—HSD17B1—Disease—KRAS—hematologic cancer	0.000599	0.000648	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN1B—hematologic cancer	0.000593	0.000642	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—hematologic cancer	0.000582	0.000629	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL2—hematologic cancer	0.000581	0.000628	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCND1—hematologic cancer	0.000566	0.000613	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JUN—hematologic cancer	0.000565	0.000611	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CA—hematologic cancer	0.00055	0.000596	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN1A—hematologic cancer	0.000548	0.000593	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTEN—hematologic cancer	0.000546	0.000591	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK8—hematologic cancer	0.000535	0.000578	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EP300—hematologic cancer	0.000521	0.000564	CbGpPWpGaD
Equilin—HSD17B1—Disease—HRAS—hematologic cancer	0.000509	0.000551	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SRC—hematologic cancer	0.000507	0.000548	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—hematologic cancer	0.000494	0.000534	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT3—hematologic cancer	0.000489	0.000529	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NRAS—hematologic cancer	0.000487	0.000528	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—hematologic cancer	0.000487	0.000528	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK3—hematologic cancer	0.000467	0.000505	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CA—hematologic cancer	0.000461	0.000499	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MYC—hematologic cancer	0.000454	0.000491	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFB1—hematologic cancer	0.000453	0.00049	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—hematologic cancer	0.00045	0.000487	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KRAS—hematologic cancer	0.00042	0.000454	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CA—hematologic cancer	0.000385	0.000417	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—hematologic cancer	0.000377	0.000408	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—hematologic cancer	0.000373	0.000404	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HRAS—hematologic cancer	0.000357	0.000386	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—hematologic cancer	0.000341	0.000369	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—hematologic cancer	0.000315	0.000341	CbGpPWpGaD
